Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Antiaversive effects of 5HT2C receptor agonists and fluoxetine in a model of panic-like anxiety in rats.

Jenck F, Moreau JL, Berendsen HH, Boes M, Broekkamp CL, Martin JR, Wichmann J, Van Delft AM.

Eur Neuropsychopharmacol. 1998 Aug;8(3):161-8.

PMID:
9716307
2.

Differences in modulation of noradrenergic and serotonergic transmission by the alpha-2 adrenoceptor antagonists, mirtazapine, mianserin and idazoxan.

de Boer TH, Nefkens F, van Helvoirt A, van Delft AM.

J Pharmacol Exp Ther. 1996 May;277(2):852-60.

PMID:
8627567
3.

Genomic organisation and functional expression of the gene encoding the human serotonin 5-HT2C receptor.

Stam NJ, Vanderheyden P, van Alebeek C, Klomp J, de Boer T, van Delft AM, Olijve W.

Eur J Pharmacol. 1994 Nov 15;269(3):339-48.

PMID:
7895773
4.

Reversal by NGF of cytostatic drug-induced reduction of neurite outgrowth in rat dorsal root ganglia in vitro.

Konings PN, Makkink WK, van Delft AM, Ruigt GS.

Brain Res. 1994 Mar 21;640(1-2):195-204.

PMID:
7911725
5.

The effect of the potential antipsychotic ORG 5222 on local cerebral glucose utilization in freely moving rats.

Room P, Tielemans AJ, De Boer T, Van Delft AM, Tonnaer JA.

Eur J Pharmacol. 1991 Dec 3;205(3):233-40.

PMID:
1687813
6.

Depletion of brain serotonin differently affects behaviors induced by 5HT1A, 5HT1C, and 5HT2 receptor activation in rats.

Berendsen HH, Broekkamp CL, van Delft AM.

Behav Neural Biol. 1991 Mar;55(2):214-26.

PMID:
1829353
7.

Antagonism of 8-OH-DPAT-induced behaviour in rats.

Berendsen HH, Broekkamp CL, Van Delft AM.

Eur J Pharmacol. 1990 Oct 2;187(1):97-103.

PMID:
2148726
8.
10.

The effect of antidepressants on aversive periaqueductal gray stimulation in rats.

Jenck F, Broekkamp CL, Van Delft AM.

Eur J Pharmacol. 1990 Feb 27;177(3):201-4.

PMID:
2107091
11.

5-HT1C receptors in the serotonergic control of periaqueductal gray induced aversion in rats.

Jenck F, Broekkamp CL, Van Delft AM.

Psychopharmacology (Berl). 1990;100(3):372-6.

PMID:
2107558
12.

A large scale, high resolution, automated system for rat sleep staging. I. Methodology and technical aspects.

Ruigt GS, Van Proosdij JN, Van Delft AM.

Electroencephalogr Clin Neurophysiol. 1989 Jul;73(1):52-63.

PMID:
2472952
13.

Local cerebral glucose uptake in anatomically defined structures of freely moving rats.

Room P, Tielemans AJ, De Boer T, Tonnaer JA, Wester J, Van den Broek JH, Van Delft AM.

J Neurosci Methods. 1989 Apr;27(3):191-202.

PMID:
2725003
14.

Opposite control mediated by central 5-HT1A and non-5-HT1A (5-HT1B or 5-HT1C) receptors on periaqueductal gray aversion.

Jenck F, Broekkamp CL, Van Delft AM.

Eur J Pharmacol. 1989 Feb 28;161(2-3):219-21.

PMID:
2524392
15.

Animal models for anxiety and response to serotonergic drugs.

Broekkamp CL, Berendsen HH, Jenck F, Van Delft AM.

Psychopathology. 1989;22 Suppl 1:2-12. Review.

PMID:
2567038
16.

Ovariectomy and subchronic estradiol-17 beta administration decrease dopamine D1 and D2 receptors in rat striatum.

Tonnaer JA, Leinders T, van Delft AM.

Psychoneuroendocrinology. 1989;14(6):469-76.

PMID:
2533695
17.
18.

Effect of metergoline, fenfluramine, and 8-OHDPAT on catalepsy induced by haloperidol or morphine.

Broekkamp CL, Oosterloo SK, Berendsen HH, van Delft AM.

Naunyn Schmiedebergs Arch Pharmacol. 1988 Aug;338(2):191-5.

PMID:
2972934
19.

The pharmacological profile of Org 6906, a potential non-sedative antidepressant that combines monoamine uptake inhibition with alpha 2-adrenolytic activity.

de Boer T, Broekkamp CL, Gower A, de Graaf JS, de Vos CJ, Rae D, Van Delft AM.

Neuropharmacology. 1988 Mar;27(3):251-60.

PMID:
2897643
20.
21.

Facilitation of amphetamine-induced rotation by muscarinic antagonists is correlated with M2 receptor affinity.

Hagan JJ, Tonnaer JA, Rijk H, Broekkamp CL, van Delft AM.

Brain Res. 1987 Apr 28;410(1):69-73.

PMID:
3580900
22.

Effects of ACTH and related peptides on medial septal self-stimulation.

Gower AJ, Broekkamp CL, van Delft AM.

Pharmacol Biochem Behav. 1986 May;24(5):1253-6.

PMID:
3014566
23.
24.

Response changes after repeated low apomorphine: dopamine autoreceptor desensitization or learning?

Nickolson VJ, van Riezen H, van Delft AM.

Psychopharmacology (Berl). 1984;83(2):188-93.

PMID:
6431472
25.

The potential therapeutic role of the enantiomers and metabolites of mianserin.

Pinder RM, Van Delft AM.

Br J Clin Pharmacol. 1983;15 Suppl 2:269S-276S.

26.

Pharmacological aspects of mianserin.

Pinder RM, van Delft AM.

Acta Psychiatr Scand Suppl. 1983;302:59-71.

PMID:
6301219
27.

Comparative pharmacology of mianserin, its main metabolites and 6-azamianserin.

Nickolson VJ, Wieringa JH, van Delft AM.

Naunyn Schmiedebergs Arch Pharmacol. 1982 Apr;319(1):48-55. No abstract available.

PMID:
6287300
28.

Alterations in local cerebral glucose utilization during chronic treatment with an ACTH 4-9 analog.

McCulloch J, Kelly PA, van Delft AM.

Eur J Pharmacol. 1982 Feb 26;78(2):151-8.

PMID:
6281031
29.
30.

Effects of intra-arterial cannulation on blood platelet consumption in rats.

Meuleman DG, Vogel GM, van Delft AM.

Thromb Res. 1980 Oct 1;20(1):45-55. No abstract available.

PMID:
7209873
31.

An automated superfusion technique for measuring circular muscle contraction. Effects of serotonin on intra- and extracranial arteries.

Lamar JC, Carati P, Schönbaum E, Van Delft AM.

Eur J Pharmacol. 1979 May 1;55(3):273-80.

PMID:
37097
33.

Behavioral and electrocortical activity in rats after neonatal intraventricular 6-hydroxydropamine administration.

Nyakas C, Van Delft AM.

Pharmacol Biochem Behav. 1975 Mar-Apr;3(2):271-7.

PMID:
1144483
34.

Circadian periodicity and stress responsiveness of the pituitary--adrenal system of rats after central administration of 6-hydroxydopamine.

Kaplanski J, van Delft AM, Nyakas C, Stoof JC, Smelik PG.

J Endocrinol. 1974 Nov;63(2):299-310. No abstract available.

PMID:
4443690
35.

The effect of 6-hydroxydopamine administration to neonatal rats on some endocrine and behavioral parameters.

van Delft AM, Nyakas C, Kaplanski J, Tilders FJ.

Arch Int Pharmacodyn Ther. 1973 Dec;206(2):403-4. No abstract available.

PMID:
4778634
36.

Circadian periodicity of pituitary-adrenal function after p-chlorophenylalanine administration in the rat.

van Delft AM, Kaplanski J, Smelik PG.

J Endocrinol. 1973 Dec;59(3):465-74. No abstract available.

PMID:
4357496
37.

Effect of central early postnatal 6-hydroxydopamine administration on brain catecholamines and pituitary-adrenal function in adulthood.

Kaplanski J, Nyakas C, van Delft AM, Smelik PG.

Neuroendocrinology. 1973-1974;13(1):123-7. No abstract available.

PMID:
4779045
38.

Exploratory activity and conditioned avoidance acquistion after early postnatal 6-hydroxydopamine administration.

Nyakas C, van Delft AM, Kaplanski J, Smelik PG.

J Neural Transm. 1973;34(4):253-66. No abstract available.

PMID:
4775136
39.

Effect of ACTH on single unit activity in the diencephalon of intact and hypophysectomized rats.

Van Delft AM, Kitay JI.

Neuroendocrinology. 1972;9(3):188-96. No abstract available.

PMID:
4333922
40.

Supplemental Content

Loading ...
Support Center